Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 26;331(12):1007-1008.
doi: 10.1001/jama.2024.2252.

GLP-1 Agonists for Obesity-A New Recipe for Success?

Dariush Mozaffarian  1   2
Affiliations

GLP-1 Agonists for Obesity-A New Recipe for Success?

Dariush Mozaffarian. JAMA. .
No abstract available

Plain language summary

This Viewpoint discusses the drawbacks of using glucagon-like peptide 1 (GLP-1) agonists to treat obesity and presents an alternative approach of initial, staged GLP-1 agonist treatment supported by long-term lifestyle programming, including medically appropriate groceries or meals (“Food Is Medicine”), to address the cost, health, and equity burdens of obesity.

PubMed Disclaimer

Comment in

  • GLP-1 Agonists for Obesity.
    Dellgren J, Emanuel EJ, Persad G. Dellgren J, et al. JAMA. 2024 Aug 27;332(8):673-674. doi: 10.1001/jama.2024.12068. JAMA. 2024. PMID: 39083262 No abstract available.
  • GLP-1 Agonists for Obesity.
    Langland JT. Langland JT. JAMA. 2024 Aug 27;332(8):674-675. doi: 10.1001/jama.2024.12065. JAMA. 2024. PMID: 39083266 No abstract available.
  • GLP-1 Agonists for Obesity.
    Kurian M, Rogers AM, Peterson RM. Kurian M, et al. JAMA. 2024 Aug 27;332(8):672-673. doi: 10.1001/jama.2024.12071. JAMA. 2024. PMID: 39083283 No abstract available.
  • GLP-1 Agonists for Obesity.
    Moran AJ, Roberto CA. Moran AJ, et al. JAMA. 2024 Aug 27;332(8):673. doi: 10.1001/jama.2024.12074. JAMA. 2024. PMID: 39083284 No abstract available.

Publication types

MeSH terms